International Business News - AMGN http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Biotechnology company Amgen Inc. said Wednesday the Food and Drug Administration will not issue a much anticipated decision this week on whether to approve an experimental blood-clotting disorder drug. http://www.ibtimes.com/articles/20080723/amgen-blood-clotting-drug-decision-delayed.htm Wed, 23 Jul 2008 10:27:28 EDT Wyeth said Wednesday its second-quarter profit fell 6.3 percent on charges for severance and other costs related to ongoing job cuts, but the drug developer still topped Wall Street expectations and raised its full-year outlook. http://www.ibtimes.com/articles/20080723/wyeth-2q-profit-falls-on-charges-for-job-cuts.htm Wed, 23 Jul 2008 19:11:50 EDT Biotech drugmaker Amgen Inc. is expected to receive a decision this week from federal regulators on its experimental drug to treat a blood-clotting disorder. http://www.ibtimes.com/articles/20080722/ahead-of-the-bell-amgen-blood-clotting-drug.htm Tue, 22 Jul 2008 06:19:54 EDT Shares throughout the biotechnology sector advanced Monday as Swiss pharmaceutical giant Roche offered to buy Genentech Inc. in potentially the biggest pharma-biotech deal of the year. http://www.ibtimes.com/articles/20080721/sector-snap-biotech-stocks-rise-on-buyout-offer.htm Mon, 21 Jul 2008 11:42:39 EDT Carl Icahn moved ahead with his attempt to overthrow Yahoo Inc.'s board of directors by submitting his final list of candidates Monday. The nominees remain the same as those he first provided in May, except the list has been whittled from 10 to nine candidates to reflect Yahoo's decision to reduce the size of its board. Here's a look at the incumbents and the Icahn-led opposition: http://www.ibtimes.com/articles/20080714/yahoos-current-board-versus-icahns-challengers.htm Mon, 14 Jul 2008 17:35:46 EDT Biotechnology company Amgen Inc. said Business Wire erroneously released a statement from the company Monday, saying the Food and Drug Administration approved its Nplate treatment for a rare type of blood-platelet deficiency condition. http://www.ibtimes.com/articles/20080714/amgen-gets-fda-approval-for-platelet-disorder-drug.htm Mon, 14 Jul 2008 12:19:16 EDT Biotechnology company Amgen Inc. said Monday late-stage study results show its developing osteoporosis drug was more successful than placebo at building bone density in men undergoing hormone therapy. http://www.ibtimes.com/articles/20080714/amgen-says-osteoporosis-drug-successful-in-study.htm Mon, 14 Jul 2008 09:59:23 EDT Diversified health care products company Johnson & Johnson said Friday it will receive $200 million from biotechnology company Amgen Inc. as part of a settlement of an antitrust lawsuit. http://www.ibtimes.com/articles/20080711/amgen-paying-j-j-200-million-in-settlement.htm Fri, 11 Jul 2008 17:32:17 EDT Shares of biotechnology companies closed mostly lower Friday with the broader market as investors focused on troubles at mortgage companies Fannie Mae and Freddie Mac and oil prices continued climbing. http://www.ibtimes.com/articles/20080711/closing-glance-biotechnology.htm Fri, 11 Jul 2008 16:14:39 EDT Shares of biotechnology companies opened mixed Friday as the broader market declined on troubles at government-backed mortgage companies Fannie Mae and Freddie Mac, and oil prices continued climbing. http://www.ibtimes.com/articles/20080711/opening-glance-biotechnology.htm Fri, 11 Jul 2008 09:55:27 EDT Drug company sales representatives will have to stop doling out coffee mugs and pens that push their products when they visit doctor's offices. But they can still sneak in the occasional free lunch. http://www.ibtimes.com/articles/20080711/new-pharma-ethics-rules-eliminate-gifts-and-meals.htm Fri, 11 Jul 2008 05:28:20 EDT Shares of biotechnology companies closed mixed Thursday as the broader market rose slightly on Dow Chemical's multibillion dollar buyout bid for rival Rohm and Haas helped offset concerns about the financial sector and energy costs. http://www.ibtimes.com/articles/20080710/closing-glance-biotechnology.htm Thu, 10 Jul 2008 16:25:30 EDT Shares of biotechnology companies opened higher Thursday with the broader market on better-than-expected monthly sales reports and Dow Chemical Co.'s $15 billion buyout offer for Rohm and Haas Co. http://www.ibtimes.com/articles/20080710/opening-glance-biotechnology.htm Thu, 10 Jul 2008 09:41:12 EDT Drug company sales representatives will have to stop doling out coffee mugs and pens that push their products when they visit doctor's offices. But they can still sneak in the occasional free lunch. http://www.ibtimes.com/articles/20080710/new-pharma-ethics-rules-eliminate-gifts-and-meals.htm Thu, 10 Jul 2008 17:32:34 EDT Shares of biotechnology companies closed mixed Wednesday as the broader market tumbled on rising oil prices and concerns over upcoming earnings reports in the technology and financial sectors. http://www.ibtimes.com/articles/20080709/closing-glance-biotechnology.htm Wed, 09 Jul 2008 16:33:52 EDT Biotech companies will likely be one of the few bright spots for investors this earnings season, as demand for essential medical treatments continues unabated despite the economic slowdown. http://www.ibtimes.com/articles/20080709/market-spotlight-biotechnology-earnings-preview.htm Wed, 09 Jul 2008 13:10:45 EDT Shares of biotechnology companies opened mixed Wednesday while the broader market slipped on rising oil prices. Here's how several key biotechnology stocks performed Wednesday: http://www.ibtimes.com/articles/20080709/opening-glance-biotechnology.htm Wed, 09 Jul 2008 10:03:29 EDT Shares of biotechnology companies closed higher Tuesday as analysts anticipate a mostly positive string of second-quarter earnings reports for key biotechnology companies in the coming weeks. http://www.ibtimes.com/articles/20080708/closing-glance-biotechnology.htm Tue, 08 Jul 2008 16:46:35 EDT Shares of biotechnology companies opened higher Tuesday as the broader market rose after Federal Reserve chairman Ben Bernanke said the central bank might extend its lending efforts to investment banks. http://www.ibtimes.com/articles/20080708/opening-glance-biotechnology.htm Tue, 08 Jul 2008 10:09:41 EDT Shares of biotechnology companies closed mixed Monday as the broader market fell over a cautious economic outlook from a Federal Reserve official and the possibility of more troubles in the financial sector. http://www.ibtimes.com/articles/20080707/closing-glance-biotechnology-ends-mixed.htm Mon, 07 Jul 2008 16:37:17 EDT